How effective is dacogen?
Overall anticancer responses were achieved in 17% of patients treated with decitabine, compared with 0% in patients treated with supportive care. Hematologic (blood) improvement occurred in 12% of patients treated with Dacogen, compared with 7% of patients treated with supportive care.
How long can you take dacogen?
Decitabine (Dacogen) Azacitidine can be injected under the skin or into a vein (IV), often for 7 days in a row, once a month.
How long does it take decitabine to work?
How long does it take for patients to respond to treatment? In the clinical study, the median time for patients to achieve some level of remission for either CR or CRh was 2 months (with a range of 0.8 to 4.2 months).
What is the life expectancy of someone with myelodysplastic syndrome?
Survival statistics for MDS
| WPSS Risk Group | Median Survival | Risk of AML (within 5 years) |
|---|---|---|
| Low | 5.5 years | 14% |
| Intermediate | 4 years | 33% |
| High | 2.2 years | 54% |
| Very high | 9 months | 84% |
Will dacogen help with AML?
WASHINGTON — Decitabine (Dacogen), a hypomethylating agent, does not appear to improve mortality in older patients with acute myelogenous leukemia (AML), FDA reviewers concluded.
Is dacogen a chemo?
Dacogen is the trade name for decitabine. In some cases, health care professionals may use the trade name Dacogen when referring to the generic drug name decitabine. Drug type: Decitibine is an anti-cancer (“antineoplastic” or “cytotoxic”) chemotherapy drug.
Is DACOGEN a chemo?
Decitabine (Dacogen®) is a Chemotherapy Regimen for Acute Myeloid Leukemia (AML)
Is DACOGEN the same as decitabine?
Dacogen is the trade name for decitabine. In some cases, health care professionals may use the trade name Dacogen when referring to the generic drug name decitabine.
Is decitabine a chemotherapy?
DECITABINE (dee SYE ta been) is a chemotherapy drug. This medicine reduces the growth of cancer cells.
How often is DACOGEN given?
Administer DACOGEN at a dose of 15 mg/m2 by continuous intravenous infusion over 3 hours repeated every 8 hours for 3 days. Repeat cycles every 6 weeks upon hematologic recovery (ANC at least 1,000/µL and platelets at least 50,000/µL) for a minimum of 4 cycles. .
What is the progression of MDS?
The pace of progression varies. In some individuals the condition worsens within a few months of diagnosis, while others have relatively little problem for several decades. In about 50 percent of cases, MDS deteriorates into a form of cancer known as acute myeloid leukemia (AML).
Can you live 10 years with MDS?
With current treatments, patients with lower-risk types of some MDS can live for 5 years or even longer. Patients with higher-risk MDS that becomes acute myeloid leukemia (AML) are likely to have a shorter life span. About 30 out of 100 MDS patients will develop AML.
